Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Choosing an index fund involves evaluating costs, tracking accuracy, and liquidity. This quick guide highlights essential factors to help you select wisely.
19,450 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
In a volatile market, you can still build lasting wealth with steady, high-yield dividend stocks hold. This article e...
Pump.fun has unveiled a record-setting compensation package for its Chief Legal Officer, signaling a competitive push...
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
Bitcoin slides to $58K as risk-off sentiment expands across digital assets, erasing roughly $120B in market value and...
Ripple's chief executive pushes back on BTC-focused tactics, praising XRP's utility. The remarks come as Strategy's S...
Starting in 2026, SECURE 2.0 requires older high earners to route catch-up contributions into Roth 401(k)s, removing ...
Ripple's XRP Ledger is moving toward an on-chain lending layer. This article explains how the ledger's 'missing layer...
Dogecoin just plunged below a critical level, triggering concern among traders and long-term holders alike. This guid...
A sharp pullback in the IGV ETF puts a spotlight on Oracle’s ability to generate free cash flow amid AI investments. ...
CoreWeave unleashed resilient US-scale growth with a massive backlog, while Nebius posted stronger margins on a small...
Short sellers now hold about 31% of SpaceX’s tradable float, a level that could ignite a volatile squeeze unless the ...